← Back
$LXRX All transactions

LEXICON PHARMACEUTICALS, INC.

M

$ Value

Shares

128,190

Price

Filed

Mar 3

Insider

Name

DeFrancesco Lisa

Title

SVP, IR and Corp Comm

CIK

0001846325

Roles

Officer

Transaction Details

Transaction Date

2026-02-28

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

168,441

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock. | Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. | Each restricted stock unit represents a contingent right to receive one share of common stock. | Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.

Filing Info

Accession No.

0001062822-26-000037

Form Type

4

Issuer CIK

0001062822

DeFrancesco Lisa's History

Date Ticker Type Value
2026-02-28 LXRX M
2026-02-28 LXRX M
2026-02-28 LXRX F $110K
2026-02-28 LXRX M
2026-02-28 LXRX M
2026-02-12 LXRX A $0
2026-02-12 LXRX A $0

Other Insiders at LXRX (90d)

Insider Bought Sold Last
Invus Global Management, LLC $2.0M 2026-02-02
DEBBANE RAYMOND $723K 2026-02-25
Coiante Scott M
SVP, Chief Financial Officer
2026-02-28
Crum Brian T
SVP, General Counsel & Secr.
2026-02-28
DeFrancesco Lisa
SVP, IR and Corp Comm
2026-02-28
Granowitz Craig B
SVP, Chief Medical Officer
2026-02-28
McDermott Wendy
SVP, Human Resources
2026-02-28
Exton Michael
Chief Executive Officer
2026-02-28
Artal Participations S.a r.l. 2026-02-17
Gopinathan Suma
SVP, Discovery
2026-02-28
Martens Rachel Yap
SVP, Partnerships & Corp Strat
2026-02-28